Table 3 Secondary outcome measures in the BIG group: comparison to baseline
From: LSVT-BIG therapy in Parkinson’s disease: physiological evidence for proprioceptive recalibration
Measure (ANOVARM) | D1 | D2 § | D3 § |
|---|---|---|---|
MDS-UPDRS III (F(2;20) = 3.2, p = 0.061) | 22.3 ± 12.3 | 18.3 ± 9.3 | 17.8 ± 10.5 |
PDQ-39 (F(2;20) = 4.6, p = 0.043*) | 19.3 ± 10.3 | 13.8 ± 6.5 (p = 0.016*) | 12.1 ± 8.6 (p = 0.052) |
NHPT [s] (F(2;20) = 3.2, p = 0.063) | 25.3 ± 3.3 | 23.5 ± 4.3 | 23.5 ± 2.6 |